Replies to post #315 on Stinkeye Aggressive Growth Fund (SAGF)

[Aiming4]

Thanks for the COR chart, I'll post a link on the COR board to it.

I've followed COR for several years and I think, at this early stage (still Phase IIa trials and no U.S. BP deal), Ampakines have an excellent chance of attracting a BP partner for Phase IIb and Phase III trials.

So the future will be fraught with additional decision points (as with ANY biotech trying to get a drug to market), but I think the odds of success right now are high.

I'll be interested to follow your swing trade technique - if you take a position in COR please let me know so I can see your style of handling it.

I'll follow up on IFUE this weekend, for now it's time to grab some shuteye... Aiming4.